The prevalence of thalassemia and sickle cell anaemia—both inherited blood disorders affecting haemoglobin—is significantly higher among Tharu tribals on the Indo-Nepal border compared to the ...

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...

Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, myelodysplastic syndromes ...

c. What treatments or interventions used for acute sickle cell crises are equivalent to parenteral narcotic medication in terms of medical severity of the underlying acute crisis (e.g., acute ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...